Being overweight in middle age raises the risk of Alzheimer's disease. Excess fat triggers inflammation and harms brain cells ...

With childhood obesity becoming the fastest growing public health concern in India, school interventions can ensure a diet ...

Depressive disorders exhibit significant comorbidity with lipid dysregulation. Clinical observations indicate that poor lifestyle factors contribute to lipid dysregulation in depressed patients. This ...

THURSDAY, Sept. 25, 2025 (HealthDay News) -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study published online Sept. 17 ...

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...

The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials database. Eli Lilly has pulled the plug on a Phase IIb trial that was ...

Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the pharma giant to the obesity and metabolic drug space from which it retreated this past ...

Obesity and obstructive sleep apnea (OSA) are closely related. Weight loss, surgery, and other treatments can improve OSA symptoms effectively.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Pfizer, which has struggled in the race for new obesity drugs, said ...

Pfizer nears $7.3B deal to acquire Metsera, targeting next-gen obesity treatments. MET-097i shows 11.3% weight loss in trials and offers monthly dosing. Acquisition positions Pfizer against Novo ...

For decades, the Democratic Republic of the Congo has endured almost continuous wars. By some estimates, they have become the deadliest since World War II, with many millions of people killed.